Activation of the transcription factor signal transducer and activator of transcription 3 (STAT3) in response to diverse stimuli can promote tumor cell survival and enhance tumor stem cell-like properties.32–34 Thus, the targeted disruption of this signal transduction pathway has emerged as a potential therapeutic strategy for cancer. Here, STAT3 is linked to neoplasm.